Concurrently, AM Best has withdrawn these Credit Ratings (ratings) as the company has requested to no longer participate in AM Best's interactive rating process.
The revision of the outlooks to stable reflects an improvement in PASHA Insurance's balance sheet strength and AM Best's expectation that the company's risk-adjusted capitalisation will remain at the strongest level, as measured by Best's Capital Adequacy Ratio (BCAR), supported by improvements in its capital management and enterprise risk management (ERM) capabilities.
PASHA Insurance significantly increased its non-proportional reinsurance protection in 2019 to mitigate catastrophe risk.
The ratings reflect PASHA Insurance's balance sheet strength, which AM Best categorises as strong, as well as its strong operating performance, limited business profile and marginal ERM.
PASHA Insurance's balance sheet strength is underpinned by its risk-adjusted capitalisation at that strongest level, supported by moderate underwriting leverage and a relatively conservative investment strategy. Factors that negatively affect the company's balance sheet strength assessment are its high dividend payout ratio, which limits growth of its capital base, its significant exposure to catastrophe losses and the high financial system risk in Azerbaijan.
The company's strong operating performance is demonstrated by a five-year weighted average combined ratio of 83.2% and return on capital and surplus of 23.5% (2014-2018). Over this period, earnings benefited from a low level of loss activity in Azerbaijan, as well as the high interest rate environment in the country. In 2018, the company generated a strong net profit of AZN 21.5 million (approximately USD 12.7 million). Prospective performance may be subject to volatility due to the challenging market conditions in Azerbaijan.
PASHA Insurance maintains a solid competitive position in Azerbaijan's small and underdeveloped insurance market, supported by its affiliation with the PASHA group and its established business relationships with large commercial customers. However, there is material concentration risk in the company's underwriting portfolio, with a single group medical client accounting for approximately one third of the company's gross written premium.